Padmanabhan, J.; Saha, B.; Powell, C.; Mo, Q.; Perez, B.A.; Chellappan, S.
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells. Cancers 2021, 13, 3906.
https://doi.org/10.3390/cancers13153906
AMA Style
Padmanabhan J, Saha B, Powell C, Mo Q, Perez BA, Chellappan S.
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells. Cancers. 2021; 13(15):3906.
https://doi.org/10.3390/cancers13153906
Chicago/Turabian Style
Padmanabhan, Jaya, Biswarup Saha, Chase Powell, Qianxing Mo, Bradford A. Perez, and Srikumar Chellappan.
2021. "Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells" Cancers 13, no. 15: 3906.
https://doi.org/10.3390/cancers13153906
APA Style
Padmanabhan, J., Saha, B., Powell, C., Mo, Q., Perez, B. A., & Chellappan, S.
(2021). Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells. Cancers, 13(15), 3906.
https://doi.org/10.3390/cancers13153906